7Baggers
The information provided in this report is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.

Processa Pharmaceuticals Inc
(NASDAQ:PCSA) 

PCSA stock logo

Processa Pharmaceuticals is committed to developing drug products aimed at improving the quality of life for patients with unmet medical needs.

Founded: 2011
CEO: David Young  
Sector: Pharmaceuticals
Industry: PHARMACEUTICAL PREPARATIONS

Share this website to your friends
Processa Pharmaceuticals Days Payable Outstanding ttm (DPO)
202303 202304 202305 202306 202307 202308 202309 202310 202311 202312 202401 202402 202403 202404 02.014.026.038.0410.0512.0514.06
Processa Pharmaceuticals Op Cashflow Per Share ttm
202209 202210 202211 202212 202301 202302 202303 202304 202305 202306 202307 202308 202309 202310 202311 202312 202401 202402 202403 202404 -6.27-5.37-4.48-3.58-2.69-1.79-0.90
Processa Pharmaceuticals Free Cashflow Per Share ttm
202209 202210 202211 202212 202301 202302 202303 202304 202305 202306 202307 202308 202309 202310 202311 202312 202401 202402 202403 202404 -6.27-5.38-4.48-3.58-2.69-1.79-0.90
Processa Pharmaceuticals Cash Per Share ttm
202209 202210 202211 202212 202301 202302 202303 202304 202305 202306 202307 202308 202309 202310 202311 202312 202401 202402 202403 202404 00.521.051.572.092.613.143.66
Processa Pharmaceuticals (GAAP) P/E ratio ttm
202209 202210 202211 202212 202301 202302 202303 202304 202305 202306 202307 202308 202309 202310 202311 202312 202401 202402 202403 202404 -2.32-1.99-1.66-1.33-0.99-0.66-0.330
Processa Pharmaceuticals P/B ratio ttm
202209 202210 202211 202212 202301 202302 202303 202304 202305 202306 202307 202308 202309 202310 202311 202312 202401 202402 202403 202404 01.322.653.975.36.627.949.27
No extra charts and metrics for this ticker.